Novel was built on a simple bet: that the industry's usual trade-off between accessible care and a sustainable business doesn't have to exist. No exam fee, a subscription model, and a doctor-to-support-staff ratio that puts far more of the client relationship in the hands of trained, well-paid support staff, freeing doctors to focus on medicine rather than the business of the visit. Co-founders Emma Harris and Brendon Laing talk through the thinking behind that model, why removing cost as a barrier to care doesn't have to mean thinner margins, and what it actually takes to build team-based medicine around the human-animal bond rather than around the doctor's calendar.

Emma Harris

Brandon Laing
AnimalBiome’s early growth was driven by products that genuinely improved the health of cats and dogs through microbiome science. But the company’s biggest acceleration came later—when it began deeply understanding how customers make decisions, build trust, and engage with pet health products. In this talk, Carlton Osborne shares the lessons AnimalBiome learned about branding, subscriptions, channel strategy, pricing, and customer behavior—and how those insights transformed a science-driven startup into a faster-growing, more customer-centric business.

Carlton Osborne
Animal health is advancing on two fronts: new modalities including mAbs, mRNA, CGT, vaccines, long-acting injectables, tides, conjugates etc. and new care models built on telehealth, remote monitoring and at-home treatment. Both change what a product must deliver, and both raise the CMC bar.
This session unpacks the five decisions that make or break commercial success: manufacturability, scalability, stability and distribution, regulatory reproducibility, and supply chain readiness with a practical lens on why cost-of-goods is uniquely decisive in animal health, and why most failures happen after proof-of-concept, not before it.
Great science earns attention. Great CMC earns the market.

Samantha Hullah, PhD
Placing the pet owner and their companions at the center of the entire animal health value chain, how do we design a future where everyone in this ecosystem wins? We’ll discuss…
- The full spectrum of information that helps define prevalence of disease and wellness needs
- Pet owners' need for convenience, transparency and accessibility
- How data unlocks accessibility, affordability, personalization and prediction
- In order for this vision to happen, what are the roadblocks we need to overcome?

Rimma Driscoll
Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure. She has worked extensively in Pharmaceuticals, Consumer Healthcare and Consumer Products businesses.

Jay Price

Matthew Salois

Jesper Nordengaard
